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Ensuring accelerated accessibility  
and affordability of treatment services 
for COVID-19 patients in Zimbabwe:  
An urgent call to action
To the Editor: Timely access to quality healthcare services is a basic 
human right. Governments globally have a responsibility to ensure 
wider coverage and access, particularly to essential and lifesaving 
healthcare services. For these reasons, there has been a strong call 
for universal health coverage. Private medical insurance promotes 
inequalities in accessing care, perpetuated by ever-widening 
socioeconomic gaps. In resource-constrained settings, the lower and 
more vulnerable social classes suffer more from disparities during 
crisis times such as the COVID-19 pandemic.
Zimbabwe, a country characterised by underinvestment in 
the public sector and unfavourable conditions for the healthcare 
workforce, has seen massive outward migration of health service 
providers to countries such as the UK, Australia, New Zealand, 
Canada and the USA.[1] As a result, Zimbabwe has been ill-prepared 
to protect its population from the negative impact of COVID-19. 
Additionally, the sustained depreciation of the local currency has 
made conditions untenable for many health workers in the COVID-
19 era, where there are increased demands on their jobs. The 
prevailing hyperinflationary environment has led to the deterioration 
of equipment and frequent stock outages of essential commodities 
and consumables in the public sector, making it difficult, and 
sometimes impossible, for patients to access COVID-19 treatment 
and care services. Lack of consumables such as personal protective 
equipment (PPE) has worsened the situation,[2] with PPE only being 
obtained earlier in the pandemic when health workers took the 
government to court to compel it to provide this essential equipment.
As patients struggle to access treatment services provided by 
the public sector, they have turned to the private sector, either to 
use established facilities or for home-based healthcare services. 
Reports have emerged of exorbitant upfront admission charges for 
COVID-19 patients, well beyond the reach of the majority, with 
essential medication also being sold at extortionate prices. For 
instance, there are reports that the scarce tocilizumab, a drug that 
has been widely prescribed for COVID-19, is being sold for over 
USD1 500 per dose, way above its cost on the market.[3] There 
have been widespread unproven reports of COVID-19 treatment 
and prevention kits, containing medicines such as ivermectin, 
doxycycline and azithromycin, being sold for exorbitant prices.[4]
There is an urgent need for the government to provide a safety net 
for the suffering patients, protecting them from over-profiteering in 
the private sector. More importantly, the government must recognise 
its role as being central in the provision of quality and accessible 
healthcare to the people. We therefore call upon the government 
to prioritise building healthcare capacity and a robust and resilient 
system ahead of other priorities, as we prepare for inevitable further 
COVID-19 waves. We also implore the government to urgently 
address healthcare workers’ genuine grievances, including demands 
for fair remuneration, health and life insurance, and provision of safe 
and adequate PPE.
Disclaimer. The views presented in this letter are those of the authors and 
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